Douglas C. Lane & Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | $2.92M | Sell |
95,240
-6,382
| -6% | -$195K | 0.08% | 133 |
|
|
2015
Q3 | $3.03M | Buy |
101,622
+5,390
| +6% | +$161K | 0.09% | 131 |
|
|
2015
Q2 | $3.06M | Buy |
96,232
+5,667
| +6% | +$180K | 0.08% | 133 |
|
|
2015
Q1 | $2.99M | Buy |
90,565
+2,726
| +3% | +$90K | 0.08% | 130 |
|
|
2014
Q4 | $2.6M | Buy |
87,839
+1,705
| +2% | +$50.4K | 0.07% | 129 |
|
|
2014
Q3 | $2.42M | Buy |
86,134
+7,227
| +9% | +$203K | 0.07% | 127 |
|
|
2014
Q2 | $2.22M | Buy |
78,907
+24
| +0% | +$676 | 0.07% | 130 |
|
|
2014
Q1 | $2.4M | Buy |
78,883
+10,684
| +16% | +$326K | 0.08% | 122 |
|
|
2013
Q4 | $1.98M | Buy |
68,199
+3,157
| +5% | +$91.7K | 0.07% | 125 |
|
|
2013
Q3 | $1.77M | Buy |
65,042
+4,185
| +7% | +$114K | 0.06% | 126 |
|
|
2013
Q2 | $1.62M | Buy |
+60,857
| New | +$1.62M | 0.06% | 128 |
|